Keywords
Abstract
Schizophrenia remains a leading cause of disability in mental disorders, accounting for approximately 40% of affected individuals. High disability rates highlight the limitations of secondary and tertiary preventive measures and indicate underutilization of psychotherapeutic interventions in clinical practice. Cognitive-behavioral therapy (CBT) has been shown to complement pharmacotherapy by addressing persistent delusional beliefs, hallucinations, and maladaptive behavioral patterns, ultimately improving remission quality and social functioning. This study explores the application and effectiveness of CBT in hospitalized patients with schizophrenia.
References
Aleksandrovna K. O. et al. Clinical and psychological characteristics of patients with alcoholism with suicidal behavior //Science and Innovation. – 2023. – Т. 2. – №. 11. – С. 399-404.
Anatolyevna S. Y. et al. Suicide prevention in adolescents with mental disorders //Science and Innovation. – 2023. – Т. 2. – №. 11. – С. 303-308.
Antsiborov S. et al. Association of dopaminergic receptors of peripheral blood lymphocytes with a risk of developing antipsychotic extrapyramidal diseases //Science and innovation. – 2023. – Т. 2. – №. D11. – С. 29-35.
Borisova Y. et al. Concomitant mental disorders and social functioning of adults with high-functioning autism/asperger syndrome //Science and innovation. – 2023. – Т. 2. – №. D11. – С. 36-41.
Habibullayevich S. S. et al. Depression and post-traumatic stress disorder in patients with alcoholism after the covid-19 pandemic //Science and Innovation. – 2023. – Т. 2. – №. 11. – С. 420-429.